
SMARCA4 Gene - GeneCards | SMCA4 Protein | SMCA4 Antibody
Mar 30, 2025 · SMARCA4 (SWI/SNF Related BAF Chromatin Remodeling Complex Subunit ATPase 4) is a Protein Coding gene. Diseases associated with SMARCA4 include Coffin-Siris …
SMARCA4 - Wikipedia
Transcription activator BRG1 also known as ATP-dependent chromatin remodeler SMARCA4 is a protein that in humans is encoded by the SMARCA4 gene. [5] The protein encoded by this …
SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy …
Switch/sucrose non-fermentable-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4-deficient undifferentiated tumor (SMARCA4-dUT) is a rare …
Inicio - smac4.com
A SMAC4 oferece soluções especializadas na gestão de ferramentas digitais, abrangendo o desenvolvimento de sites otimizados, processamento e otimização de dados de sites. Além …
SMARCA4 gene - MedlinePlus
The SMARCA4 gene provides instructions for making a protein called BRG1, which forms one piece (subunit) of several different protein groupings called SWI/SNF protein complexes. …
SMARCA4-deficient pulmonary adenocarcinoma: …
Our study highlights (1) the morphological diversity of SMARCA4-deficient lung adenocarcinoma, (2) the consistent absence of expression of TTF1 in the presence of expression of HepPar-1, …
SMARCA4: Current status and future perspectives in non-small-cell …
Feb 1, 2023 · SMARCA4, also known as transcription activator, is an ATP-dependent catalytic subunit of SWI/SNF (SWItch/Sucrose NonFermentable) chromatin-remodeling complexes that …
SMARCA4突变与治疗策略 - 知乎 - 知乎专栏
卵巢高钙血症型小细胞癌(Small cell carcinoma of the ovary of hypercalcemic type, SCCOHT)属于一种侵袭性非常强的恶性肿瘤,通常发生于年轻的女性,其特征是具有SMARCA4基因突 …
The role of TGF-β/SMAD4 signaling in cancer - PMC
SMAD4, which serves as the central mediator of TGF-β signaling, is specifically inactivated in over half of pancreatic duct adenocarcinoma, and varying degrees in many other types of …
The immune regulation and therapeutic potential of the SMAD
Mar 21, 2024 · In addition, SMAD3, SMAD6, and SMAD7 were lowly expressed in stage II breast cancer, while SMAD4 and SMAD2 were lowly expressed in stage III cancer. Furthermore, the …
- Some results have been removed